Latest News | Dec 19, 2022

The Week in Review in Prescription Drug Pricing

After patients scored a huge goal against Big Pharma with passage of drug price reforms in the Inflation Reduction Act, things are looking Messi within the industry ⚽??

Welcome To The Week In Review.

  1. Members Of Congress Call Out Big Pharma For Covid Vaccine Price Gouging

2. Case Study: Death Sentence For Hepatitis C Patients In Prisons

3. Spotlight On AbbVie

One more thing: A reminder that the next two drug price provisions of the Inflation Reduction Act will go into effect next month. Starting January 1, Medicare beneficiaries will get their vaccines for free and patients on Medicare Part D will have their insulin copays capped at $35 monthly. We couldn’t be more excited for all the Inflation Reduction Act drug price reforms to be implemented. Patients like Brenda and Meg need relief from high drug prices.

Have a great weekend, everyone!

Icon of the year? Tie between the new drug price reforms in the Inflation Reduction Act and Michelle Yeoh. That’s Wicked cool. 

Welcome To The Week In Review.

  1. Time To Crack Down On Sham Citizen Petitions

2. Questions Answered By P4AD’s Merith Basey

3. What To Expect In 2023

4. Perpetual Pandemic Price Gouging

5. Groundbreaking Treatments, Record-breaking Prices

Have a great weekend, everyone!

Welcome To The Week In Review.

  1. Inflation Reduction Act: A Victory For Patients

2. Big Pharma Watchdog Alerts

3. Spotlight on Congress: Drug Prices Matter

BONUS: This #WorldAIDSDay, we recognized that people living with HIV/AIDS face exorbitant prices for essential drugs because of price gouging from Big Pharma. Gilead Sciences, which has a monopoly on many essential HIV and AIDS medications, price gouges patients taking its HIV antiviral treatment Biktarvy, charging more than $3,500 a month for a drug that is keeping people alive. We must continue to fight for equitable access to life-saving drugs. 

Have a great weekend, everyone!

Happy Thanksgiving from P4AD! We’re immensely grateful for the historic progress made to lower drug prices this year.

Welcome To The Week In Review.

  1. Election Results: Votes For Lower Drug Prices

2. #WorldDiabetesDay

3. STAT Summit 2022

STAT’S RACHEL COHRS, DAVID MITCHELL, AND GUNNAR ESIASON

Have a great weekend, everyone!

Happy Veterans Day! Hope everyone is resting up post-election.

Welcome To The Week In Review.

  1. Drug Pricing + The Election

2. We Need Patent Reform

3. Lower Drug Prices Now

Have a great weekend, everyone!

This No-vember we’re saying no to high drug prices.

Welcome To The Week In Review.

  1. Sheldon and President Biden

2. Patients Say No To GOP Bill

3. No Good Reason For High Rx Prices

4. Patients Are Suffering From High Drug Prices

5. Big Pharma’s Latest Scapegoat, Same BS

?️BONUS: It’s nearly election day! And drug prices are still top of mind as Americans cast their ballots. Patient advocate Jackie Trapp, who lives with a ​​rare blood cancer, told CBS this week that she’s planning on voting for Democrats, and that “she’s looking forward to seeing those [drug] costs drop in coming years as drug-pricing provisions of the Inflation Reduction Act kick in.”

Have a great weekend, everyone!

Thanks to the Inflation Reduction Act, millions of patients won’t get Tricked by Big Pharma, only Treated to lower drug prices ?

Welcome To The Week In Review (a day early, as P4AD is closed today).

  1. Popular Provisions

2. Patient Feature: Therese Humphrey Ball

3. Patients Footing The Bills

Have a great weekend, everyone!

Pharma should not be left to their own devices
They come with prices
Patients end up in crisis ? 

Welcome To The Week In Review.

  1. New Study: 1 in 5 Ration Insulin

2. Voters Care About Drug Prices

3. Pandemic Profiteering

BONUS WATCH: Check out the new documentary White Coat Rebels, which dives into Big Pharma’s power, the medical profession, and the activists who are fighting back against the status quo. In particular, the film features the powerful stories of two fierce medical students from Universities Allied for Essential Medicines (UAEM), where our very own Merith Basey was previously executive director before joining P4AD!

Have a great weekend, everyone!